Literature DB >> 8073158

Mucosal leishmaniasis due to Leishmania (Viannia) braziliensis L(V)b in Três Braços, Bahia-Brazil.

P D Marsden1.   

Abstract

Brazilian mucosal leishmaniasis is briefly reviewed, emphasis being given to recent advances clinical management. Patients continue to occupy much hospital bed space and in some cases are notoriously difficult to treat. Indefinite follow up is recommended. Many aspects of the aetiology remain mysterious although Leishmania (Viannia) braziliensis is the most common organism isolated. Perspectives for a more effective treatment, oral and cheap, are still remote.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8073158     DOI: 10.1590/s0037-86821994000200007

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  11 in total

1.  Detection of Leishmania in unaffected mucosal tissues of patients with cutaneous leishmaniasis caused by Leishmania (Viannia) species.

Authors:  Roger Adrian Figueroa; Leyder Elena Lozano; Ibeth Cristina Romero; Maria Teresa Cardona; Martin Prager; Robinson Pacheco; Yira Rosalba Diaz; Jair Alexander Tellez; Nancy Gore Saravia
Journal:  J Infect Dis       Date:  2009-08-15       Impact factor: 5.226

2.  Molecular epidemiology and in vitro evidence suggest that Leishmania braziliensis strain helps determine antimony response among American tegumenary leishmaniasis patients.

Authors:  Silvana C Silva; Luiz Henrique Guimarães; Juliana A Silva; Viviane Magalhães; Lilian Medina; Adriano Queiroz; Paulo Roberto L Machado; Albert Schriefer
Journal:  Acta Trop       Date:  2017-10-16       Impact factor: 3.112

3.  Effects of sand fly vector saliva on development of cutaneous lesions and the immune response to Leishmania braziliensis in BALB/c mice.

Authors:  H C Lima; R G Titus
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

4.  Mucocutaneous Leishmaniasis: clinical markers in presumptive diagnosis.

Authors:  João Luiz Cioglia Pereira Diniz; Manoel Otávio da Rocha Costa; Denise Utsch Gonçalves
Journal:  Braz J Otorhinolaryngol       Date:  2011-06

5.  Progress of Mucocutaneous Leishmaniasis to Drug Nonresponsive Diffuse Cutaneous Leishmaniasis in Ethiopia. A Case Report.

Authors:  Banchamlak Tegegne; Getaneh Alemu
Journal:  Int Med Case Rep J       Date:  2020-10-20

6.  Association between an emerging disseminated form of leishmaniasis and Leishmania (Viannia) braziliensis strain polymorphisms.

Authors:  Adriano Queiroz; Rosana Sousa; Claudia Heine; Manuela Cardoso; Luiz Henrique Guimarães; Paulo Roberto Lima Machado; Edgar M Carvalho; Lee W Riley; Mary E Wilson; Albert Schriefer
Journal:  J Clin Microbiol       Date:  2012-10-03       Impact factor: 5.948

7.  Three Leishmania/L. species--L. infantum, L. major, L. tropica--as causative agents of mucosal leishmaniasis in Iran.

Authors:  Sadegh Shirian; Ahmad Oryan; Gholam Reza Hatam; Yahya Daneshbod
Journal:  Pathog Glob Health       Date:  2013-07       Impact factor: 2.894

8.  Resistance of Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis to nitric oxide correlates with disease severity in Tegumentary Leishmaniasis.

Authors:  Angela Giudice; Ilza Camada; Paulo T G Leopoldo; Júlia M B Pereira; Lee W Riley; Mary E Wilson; John L Ho; Amelia Ribeiro de Jesus; Edgar M Carvalho; Roque P Almeida
Journal:  BMC Infect Dis       Date:  2007-02-22       Impact factor: 3.090

Review 9.  Decentralized control of human visceral leishmaniasis in endemic urban areas of Brazil: a literature review.

Authors:  Sonia S Menon; Rodolfo Rossi; Leon Nshimyumukiza; Kate Zinszer
Journal:  Trop Med Health       Date:  2016-04-21

10.  Interventions for American cutaneous and mucocutaneous leishmaniasis.

Authors:  Mariona Pinart; José-Ramón Rueda; Gustavo As Romero; Carlos Eduardo Pinzón-Flórez; Karime Osorio-Arango; Ana Nilce Silveira Maia-Elkhoury; Ludovic Reveiz; Vanessa M Elias; John A Tweed
Journal:  Cochrane Database Syst Rev       Date:  2020-08-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.